Search by Drug Name or NDC
NDC 52183-0223-30 TAGAMET 200 mg/1 Details
TAGAMET 200 mg/1
TAGAMET is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Prestige Brands Holdings, Inc.. The primary component is CIMETIDINE.
MedlinePlus Drug Summary
Cimetidine is used to treat ulcers; gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and injury of the food pipe (esophagus); and conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome. Over-the-counter cimetidine is used to prevent and treat symptoms of heartburn associated with acid indigestion and sour stomach. Cimetidine is in a class of medications called H2 blockers. It decreases the amount of acid made in the stomach.
Related Packages: 52183-0223-30Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Cimetidine
Product Information
NDC | 52183-0223 |
---|---|
Product ID | 52183-223_e042ef55-48d2-43c6-91d1-55becd1f9f7c |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | TAGAMET |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | cimetidine |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 200 |
Active Ingredient Units | mg/1 |
Substance Name | CIMETIDINE |
Labeler Name | Prestige Brands Holdings, Inc. |
Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA020238 |
Listing Certified Through | 2024-12-31 |
Package
NDC 52183-0223-30 (52183022330)
NDC Package Code | 52183-223-30 |
---|---|
Billing NDC | 52183022330 |
Package | 3 BLISTER PACK in 1 BOX (52183-223-30) / 10 TABLET in 1 BLISTER PACK |
Marketing Start Date | 2023-02-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |